{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-009690","form_type":"8-K","ticker":"VICP","cik":"0001468639","company_name":"Vicapsys Life Sciences, Inc.","filed_at":"2022-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.826991+00:00","generated_at":"2026-06-26T07:54:49.911134+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vicapsys Life Sciences appoints Federico Pier as CEO, effective Feb 15, 2022","bullets":["Federico Pier appointed CEO effective Feb 15, 2022; previously interim CEO since Aug 2020 and Executive Chairman since May 2019.","Pier has 25+ years of experience in reverse mergers, structured finance, convertible debt, and equity; past roles at Oppenheimer & Co. and Bear Stearns.","Company develops VICAPSYN for transplantation and VYBRIN for post-surgical adhesions; trades OTC under symbol VICP.","The appointment was announced via press release dated April 12, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-009690","json":"https://secwatch.observer/filing/0001493152-22-009690.json","markdown":"https://secwatch.observer/filing/0001493152-22-009690.md","text":"https://secwatch.observer/filing/0001493152-22-009690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468639/000149315222009690/0001493152-22-009690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468639/000149315222009690/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:54:49.911134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a498f34caa","claim":"Federico Pier was appointed as Chief Executive Officer at Vicapsys Life Sciences, Inc..","evidence_excerpt":"On February 15, 2022, the Board of Directors (the “Board”) of Vicapsys Life Sciences, Inc. (the “Company”) appointed Federico Pier as Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1468639/000149315222009690/0001493152-22-009690-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}